Genes encoding chavicol/eugenol synthase from the creosote bush
Particular aspects provide novel methods for redirecting carbon allocation in plants or cell culture from lignification to inherently more useful and tractable materials, and to facilitate the generation of, e.g., biofuels from the remaining plant ro culture biomass. Particular aspects provided novel methods for converting monolignols into allyl/propenyl phenols, and for chavicol/eugenol formation or production. Additional aspects relate to the discovery of novel chavicol/eugenol synthases that convert p-coumaryl/coniferyl alcohol esters into chavicol/eugenol, and to novel compositions (e.g., novel proteins and nucleic acids encoding same), and novel methods using same for producing or forming chavicol/eugenol and other derivatives in cell culture and/or genetically modified plants, and for re-engineering the composition of plant biomass. Particular aspects provide novel methods for generation in culture or in planta of liquid/combustible allyl/propenyl phenols, and these phenolic products are utilized for (non-ethanol) biofuel/bioenergy purposes, while the remaining plant biomass facilitates the generation of other biofuels.
1. A recombinant expression vector, comprising at least one nucleic acid sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2, or a polypeptide comprising an amino acid sequence that is at least 99%, 98%, 97%, 96%, or 95% identical to SEQ ID NO: 2, the at least one nucleic acid sequence in operative association with transcriptional and translational regulatory regions or sequences suitable to provide for expression of the encoded polypeptide in a host cell, wherein the encoded polypeptide comprises a NADH-binding domain having a lysine residue corresponding to amino acid position 133 of SEQ ID NO: 2, and the encoded polypeptide converts p-coumaryl or coniferyl alcohol esters into chavicol, eugenol, or estragole.
2. A recombinant expression vector, comprising at least one nucleic acid sequence selected from the group consisting of SEQ ID NOS: 1, 3, 17, 19, and 21 wherein the nucleic acid sequence encodes a polypeptide comprising the amino acid sequence SEQ ID NO: 2, 4, 18, 20, or 22.
3. The recombinant expression vector of claim 1 , wherein the host cell is a plant cell, yeast cell, bacterial cell, or insect cell.
4. The recombinant expression vector of claim 3 , wherein the host cell is a plant cell.
5. A host cell, transformed with a recombinant expression vector comprising at least one nucleic acid sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2, or a polypeptide comprising an amino acid sequence that is at least 99%, 98%, 97%, 96%, or 95% identical to SEQ ID NO: 2, the at least one nucleic acid sequence in operative association with transcriptional and translational regulatory regions or sequences suitable to provide for expression of the encoded polypeptide in the host cell, wherein the encoded polypeptide comprises a NADH-binding domain having a lysine residue corresponding to amino acid position 133 of SEQ ID NO: 2, and the encoded polypeptide converts p-coumaryl or coniferyl alcohol esters into chavicol, eugenol, or estragole.
6. The host cell of claim 5 , wherein the host cell is a plant cell.
7. A host cell, comprising a first recombinant DNA construct and a second recombinant DNA construct, wherein
the first recombinant DNA construct comprises a first DNA sequence encoding a polypeptide comprising the amino acid sequence SEQ ID NO: 2, or a polypeptide comprising an amino acid sequence that is at least 99%, 98%, 97%, 96%, or 95% identical to SEQ ID NO: 2, the first DNA sequence in operative association with transcriptional and translational regulatory regions or sequences suitable to provide for expression of the encoded polypeptide in the host cell,
wherein the encoded polypeptide comprises a NADH-binding domain having a lysine residue corresponding to amino acid position 133 of SEQ ID NO: 2, and the encoded polypeptide converts p-coumaryl or coniferyl alcohol esters into chavicol, eugenol, or estragole, and
wherein the second recombinant DNA construct comprises a second DNA sequence encoding an acyl transferase suitable for acylation on monolignols forming esters, the second DNA sequence in operative association with transcriptional and translational regulatory regions or sequences suitable to provide for expression of the encoded acyl transferase in the host cell.
8. The host cell of claim 7 , wherein the host cell is a plant cell, and wherein the first and second recombinant DNA constructs are present as parts of a single recombinant DNA construct, or are present on separate recombinant DNA constructs.
9. The host cell of claim 7 , wherein the host cell is a plant cell, yeast cell, bacterial cell, or insect cell.
10. The host cell of claim 9 , wherein the host cell is a plant cell.
11. A plant having at least one cell transformed with the recombinant expression vector of claim 1 .
12. A plant seed comprising at least one cell transformed with the recombinant expression vector of claim 1 .
13. A method of making a re-engineered cultured cell or plant having a re-engineered biomass composition comprising
introducing into a cultured cell or plant, a recombinant expression vector
to provide for expression of a regiospecific reductase suitable to transfer a hydride to either the C-7position, or the C-9 position of at least one monolignol acyl ester or to a quinone methide derivative thereof, to provide at least one propenyl phenol derivative,
wherein the recombinant expression vector comprises at least one nucleic acid sequence that encodes a polypeptide comprising an amino acid sequence selected from the group consisting of:
SEQ ID NO: 2;
a polypeptide comprising an amino acid sequence that is at least 99%, 98%, 97%, 96%, or 95% identical to SEQ ID NO:2, wherein the polypeptide comprises a NADH-binding domain having a lysine residue corresponding to amino acid position 133 of SEQ ID NO: 2, and the polypeptide converts p-coumaryl or coniferyl alcohol esters into chavicol, eugenol, or estragole; and
SEQ ID NO: 6,
the at least one nucleic acid sequence in operative association with transcriptional and translational regulatory regions or sequences suitable to provide for expression of the encoded polypeptide in the cultured cell or plant,
thereby making a re-engineered cultured cell or plant and thereby re-engineering the biomass composition of the re-engineered cultured cell or plant.
14. The method of claim 13 , further comprising expression of at least one monolignol acyl transferase suitable for acylating at least one monolignol to form the at least one monolignol acyl ester.
15. The method of claim 14 , wherein the monolignol acyl transferase is that of Larrea tridentata.
16. The method of claim 13 , wherein the at least one monolignol acyl ester comprises p-coumaryl alcohol ester or coniferyl alcohol ester, and wherein the at least one propenyl phenol derivative comprises eugenol, chavicol, or estragole.
17. The method of claim 13 , wherein the re-engineering of the biomass composition diverts monolignol carbon flow away from lignin biopolymer formation in the re-engineered cultured cell or plant.
18. The method of claim 13 , wherein the re-engineering of the biomass composition converts monolignols into propenyl phenols in the re-engineered cultured cell or plant.
19. The method of claim 13 , wherein the re-engineering of the biomass composition alters the amount or composition of lignins in the re-engineered cultured cell or plant.
20. The method of claim 19 , wherein the altered amount or composition of lignins alters the dynamic modulus of the re-engineered cultured cell or plant relative to a control cell or plant.
21. The method of claim 20 , wherein the amount of lignins is reduced and the dynamic modulus is reduced relative to a control cell or plant.
22. The method of claim 19 , wherein the altered amount or composition of lignins alters the formation of reaction tissue in the re-engineered cultured cell or plant relative to a control cell or plant.
23. The method of claim 22 , wherein the amount of lignins is reduced and the amount of reaction tissue is increased and/or the composition of reaction tissue is altered relative to a control cell or plant.
24. The method of claim 19 , wherein the altered amount or composition of lignins alters the antimicrobial, analgesic, or plant defense properties of the re-engineered cultured cell or plant relative to a control cell or plant.
25. The method of claim 24 , wherein the amount of lignins is reduced and the amount of antimicrobial, analgesic, or plant defense properties is increased relative to a control cell or plant.
26. The method of claim 19 , wherein the altered amount or composition of lignins alters the flavor or fragrance properties of the re-engineered cultured cell or plant relative to a control cell or plant.
27. The method of claim 26 , wherein the amount of lignins is reduced and alters the flavor or fragrance properties of the re-engineered cultured cell or plant relative to a control cell or plant.
28. The method of claim 13 , further comprising isolating the at least one propenyl phenol derivative from the re-engineered cultured cell or plant to provide for at least one of: an isolated propenyl phenol derivative or biofuel; a propenyl phenol-depleted cell culture material; and a propenyl phenol-depleted plant material.
29. The method of claim 28 , further comprising making, from the at least one isolated propenyl phenol derivative, at least one product selected from the group consisting of antibacterials, plant defense agents, analgesic agents, flavoring agents, polymer building blocks, and biofuels.
30. The method of claim 28 , further comprising fermenting at least one of the propenyl phenol-depleted cell culture material and the propenyl phenol-depleted plant material.
31. The method of claim 30 , wherein the fermenting comprises fermenting to produce ethanol.
32. The method of claim 28 , further comprising producing wood, pulp, or paper products using at least one of the propenyl phenol-depleted cell culture material and the propenyl phenol-depleted plant material.
33. The method of claim 13 , further comprising making, from the re-engineered cultured cell or plant, at least one product selected from the group consisting of antibacterials, plant defense agents, analgesic agents, flavoring agents, polymer building blocks, and biofuels.
34. The method of claim 13 , further comprising fermenting the re-engineered cultured cell or plant.
35. The method of claim 34 , wherein fermenting comprises fermenting to produce ethanol.
36. The method of claim 13 , wherein the recombinant expression vector comprises at least one nucleic acid sequence that encodes a polypeptide comprising an amino acid sequence selected from the group consisting of
SEQ ID NO:2, and
a polypeptide sequence that is at least 99%, 98%, 97%, 96% or 95% identical to SEQ ID NO: 2,
wherein the polypeptide comprises a NADH-binding domain having a lysine residue corresponding to amino acid position 133 of SEQ ID NO: 2, and the polypeptide converts p-coumaryl or coniferyl alcohol esters into chavicol, eugenol, or estragole.